Efficacy of salvage with decitabine (DAC) for high-risk (HR)-MDS and advanced CMML after azacitidine (AZA) treatment failureT. Braun,A. Cherait,M. Rigal,S. Brechignac, S. Thepot,C. Gardin,L. Ades,P. FenauxLeukemia Research（2013）引用 0|浏览13暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
